Found: 9
Select item for more details and to access through your institution.
Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.837115
- By:
- Publication type:
- Article
HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.871558
- By:
- Publication type:
- Article
SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.836446
- By:
- Publication type:
- Article
KAT2A Promotes Hepatitis B Virus Transcription and Replication Through Epigenetic Regulation of cccDNA Minichromosome.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2021.795388
- By:
- Publication type:
- Article
SIRT6 Inhibitor, OSS_128167 Restricts Hepatitis B Virus Transcription and Replication Through Targeting Transcription Factor Peroxisome Proliferator-Activated Receptors α.
- Published in:
- Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01270
- By:
- Publication type:
- Article
Correction: RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, p. 1, doi. 10.1186/s13046-023-02929-1
- By:
- Publication type:
- Article
Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179605
- By:
- Publication type:
- Article
NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma.
- Published in:
- Cell Communication & Signaling, 2019, v. 17, n. 1, p. 1, doi. 10.1186/s12964-019-0491-7
- By:
- Publication type:
- Article